Two-room dermatology clinic in Abu Dhabi

Sale and operating context

Sale structure

Controlling stake (51%+)

Availability

Yes

Estimated buyer entry costs (AED)

151000

Additional initial working capital (AED)

153000

Included

Operating business and handover of supplier contracts

Excluded

Property, where owned

Years operating

9

Owner and staff

Owner works in the business daily; 17 staff

Premises

Leased

Lease or ownership

Lease to 2027

Transition support

6 months handover and introductions

Reason for sale

Owner relocating

Financial basis and assumptions

Annual revenue: AED 4,390,000. EBITDA: AED 1,129,000.

Period: FY2024. Basis: Management accounts; Adjustments: None.

Cash yield divides seller-provided annual buyer cash flow by asking price plus supplied entry costs and additional working capital. Simple payback assumes constant positive annual cash flow; it excludes exit proceeds and the time value of money. Cash yield is not total ROI. For stake and asset sales, supplied asking price and cash flow relate to the interest or assets offered. Confirm tax, management pay, reinvestment, distributions and operating costs during due diligence. Figures have not been independently verified. Returns and availability are not guaranteed.